Results for standardterapi translation from Swedish to English

standardterapi (n= 524)
standard therapy (n= 524) †

standardterapi (n=524) †
differences*

aprepitantbehandling (n=520) standardterapi (n=523)
aprepitant regimen (n=520) standard therapy (n=523)

aprepitantbehandling (n=432) standardterapi (n=424) 90 procent patienter
aprepitant regimen (n=432) standard therapy (n=424) 90%

patienter med latent tuberkulos ska behandlas med antimykobakteriell standardterapi innan behandling med roactemra inleds.
patients with latent tb should be treated with standard anti-mycobacterial therapy before initiating roactemra.

det ges i kombination med standardterapi som innehåller betablockerare eller till patienter som inte kan behandlas med betablockerare.
it is used in combination with standard therapy including beta-blockers, or in patients who cannot be treated with beta-blockers.

en patient med standardterapi hade data enbart från den sena fasen och exkluderades från den totala analysen och analys av akut fas.
* the confidence intervals were calculated with no adjustment for gender and concomitant chemotherapy, which were included in the primary analysis of odds ratios and logistic models. † one patient in the aprepitant regimen only had data in the acute phase and was excluded from the overall and delayed phase analyses; one patient in the standard regimen only had data in the delayed phase and was excluded from the overall and acute phase analyses.

hypertensionen var oftast mild till måttlig, uppträdde tidigt under behandlingen och svarade på behandling med antihypertensiv standardterapi.
hypertension was usually mild to moderate, occurred early in the course of treatment, and was amenable to management with standard antihypertensive therapy.

kronisk hjärtsvikt orsakad av klaffinsufficiens hos hund i kombination med standardterapi (inkluderande vid behov diuretika).
for use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

prilactone används i kombination med ”standardterapi” (andra hjärtmediciner, även urindrivande medel om det behövs).
prilactone is used in combination with ‘standard therapy’ (other heart medicines, including diuretic support where necessary).

i en långsiktig studie visade hundar som behandlades med prilactone också mindre försämring av hjärtsjukdomen i jämförelse med hundar som behandlades enbart med ”standardterapi”.
in a long term study, the dogs treated with prilactone also showed less deterioration of their heart disease compared to the dogs which were treated only with ‘standard therapy’.

aprepitant sattes ut till följd av biverkningar hos 0, 6% av patienter som behandlades med aprepitant jämfört med 0, 4% av patienterna som behandlades med standardterapi.
aprepitant was discontinued due to adverse reactions in 0.6% of patients treated with the aprepitant regimen compared with 0.4% of patients treated with standard therapy.

aprepitant sattes ut till följd av biverkningar hos 0. 6% av patienterna som behandlades med aprepitant, jämfört med 0, 4% av patienterna som behandlades med standardterapi.
aprepitant was discontinued due to adverse reactions in 0.6% of patients treated with the aprepitant regimen compared with 0.4% of patients treated with standard therapy.

resultaten av studierna visade att hundar med kronisk hjärtinsufficiens som orsakats av fel på hjärtklaffarna som gavs prilactone tabletter som tillägg till en annan hjärtmedicin (”standardterapi”) hade längre överlevnadstid än hundar som erhöll standardterapi plus placebotabletter.
the results of the studies showed that dogs with congestive heart failure caused by faulty heart valves that were given prilactone tablets in addition to another heart medicine (‘standard therapy’), had a longer survival time than the dogs that received the standard therapy plus placebo tablets.

efter mikrobiologisk dokumentering av orsakande organismer och risk/ nytta- bedömning, kan dock ciprofloxacin, i mycket sällsynta fall, förskrivas till dessa patienter för behandling av vissa svåra infektioner, särskilt vid tillfällen där standardterapi misslyckats eller bakterieresistens, när mikrobiologiska data motiverar användningen av ciprofloxacin.
nevertheless, in very rare instances, after microbiological documentation of the causative organism and evaluation of the risk/ benefit balance, ciprofloxacin may be prescribed to these patients for the treatment of certain severe infections, particularly in the event of failure of the standard therapy or bacterial resistance, where the microbiological data may justify the use of ciprofloxacin.